UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Gestational Diabetes and Type 2 Diabetes in Reproductive-Aged Women With Polycystic Ovary Syndrome

The journal of clinical endocrinology and metabolism, 2014-03, Vol.99 (3), p.E447-E452

2014

Volltextzugriff (PDF)

Emergency treatment of hypoglycaemia: a guideline and evidence review

Diabetic medicine, 2017-09, Vol.34 (9), p.1205-1211

2017

Volltextzugriff (PDF)

Young‐onset type 2 diabetes and younger current age: increased susceptibility to retinopathy in contrast to other complications

Diabetic medicine, 2020-06, Vol.37 (6), p.991-999

2020

Volltextzugriff (PDF)

The association of smoking status with glycemic control, metabolic profile and diabetic complications– Results of the Australian National Diabetes Audit (ANDA)

Journal of diabetes and its complications, 2020-09, Vol.34 (9), p.107626-107626, Article 107626

2020

Volltextzugriff (PDF)

The contribution of diet, physical activity and sedentary behaviour to body mass index in women with and without polycystic ovary syndrome

Human reproduction (Oxford), 2013-08, Vol.28 (8), p.2276-2283

2013

Volltextzugriff (PDF)

Contraception use and pregnancy outcomes in women with polycystic ovary syndrome: data from the Australian Longitudinal Study on Women's Health

Human reproduction (Oxford), 2014-04, Vol.29 (4), p.802-808

2014

Volltextzugriff (PDF)

Impact of different glycaemic treatment targets on pregnancy outcomes in gestational diabetes

Diabetic medicine, 2019-02, Vol.36 (2), p.177-183

2019

Volltextzugriff (PDF)

The association between Polycystic Ovary Syndrome (PCOS) and metabolic syndrome: a statistical modelling approach

Clinical endocrinology (Oxford), 2015-12, Vol.83 (6), p.879-887

2015

Volltextzugriff (PDF)

A lifestyle intervention programme for the prevention of Type 2 diabetes mellitus among South Asian women with gestational diabetes mellitus [LIVING study]: protocol for a randomized trial

Diabetic medicine, 2019-02, Vol.36 (2), p.243-251

2019

Volltextzugriff (PDF)

Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS

Endocrine, 2006-08, Vol.30 (1), p.45-54

2006

Volltextzugriff (PDF)

Caution in clinical interpretation of population level administrative data

BJOG : an international journal of obstetrics and gynaecology, 2017-04, Vol.124 (5), p.814-814

2017

Volltextzugriff (PDF)

Treatment of Dyslipidemia and Cardiovascular Outcomes: The Journey So Far-Is This the End for Statins?

Clinical pharmacology and therapeutics, 2014-08, Vol.96 (2), p.192-205

2014

Volltextzugriff (PDF)

ADVANCE and glycaemia thresholds: a need to clarify the statistical approach. Reply to Currie CJ [letter]

Diabetologia, 2012-08, Vol.55 (8), p.2300-2300

2012

Volltextzugriff (PDF)

The contribution of diet, physical activity and sedentary behaviour to body mass index in women with and without polycystic ovary syndrome

Fertility and sterility, 2013-09, Vol.100 (3), p.S352-S352

2013

Volltextzugriff (PDF)

Erratum to: Intensive glucose control and risk of cancer in patients with type 2 diabetes

Diabetologia, 2013-09, Vol.56 (9), p.2105-2106

2013

Volltextzugriff (PDF)

Novel inflammatory markers in overweight women with and without polycystic ovary syndrome and following pharmacological intervention

Journal of endocrinological investigation, 2010-04, Vol.33 (4), p.258-265

2010

Volltextzugriff (PDF)

Semaglutide for the secondary prevention of cardiovascular disease in people with overweight or obesity, but without diabetes: a cost-effectiveness analysis

European heart journal, 2024-10, Vol.45 (Supplement_1)

2024

Volltextzugriff (PDF)

Early lowering of LDL-C is a more cost-effective strategy than lowering LDL-C later in life: a cost-effectiveness analysis using Mendelian Randomisation

European heart journal, 2023-11, Vol.44 (Supplement_2)

2023

Volltextzugriff (PDF)

P283 - Déterminants de la variation du poids dans l’étude ADVANCE

Diabetes & metabolism, 2011, Vol.37 (1), p.A100-A100

2011

Volltextzugriff (PDF)

Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management

The lancet. Diabetes & endocrinology, 2019-05, Vol.7 (5), p.385-396

2019

Volltextzugriff (PDF)

The effects of statins on cardiovascular and inflammatory biomarkers in primary prevention: A systematic review and meta-analysis

European heart journal, 2023-11, Vol.44 (Supplement_2)

2023

Volltextzugriff (PDF)

Is Semaglutide Cost-Effective for the Secondary Prevention of Cardiovascular Disease in People with Overweight or Obesity in Australia?

Heart, lung & circulation, 2024-08, Vol.33, p.S523-S523

2024

Volltextzugriff (PDF)

Evaluating the Cost-Effectiveness of Immediate Versus 5-Year Risk-Guided Initiation of Treatment for Primary Prevention of Cardiovascular Disease in Australia

Heart, lung & circulation, 2024-08, Vol.33, p.S400-S400

2024

Volltextzugriff (PDF)

Immediate Vs 5-Year Risk-Guided Initiation of Treatment for Primary Prevention of Cardiovascular Disease in 40-Year-Old Australians

Heart, lung & circulation, 2024-08, Vol.33, p.S404-S404

2024

Volltextzugriff (PDF)

EValuation Of PoLygenic Scores and CT ImAging In Risk Factor Modification in Patients with DiabEtes (VOLTAIRE): Rationale and Design

Heart, lung & circulation, 2024-08, Vol.33, p.S350-S350

2024

Volltextzugriff (PDF)

1 – 25 von 293

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(284)
Mit Volltextzugriff
(251)

Publikationsform

Artikel
(292)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Gestational Diabetes and Type 2 Diabetes in Reproductive-Aged Women With Polycystic Ovary Syndrome

Emergency treatment of hypoglycaemia: a guideline and evidence review

Young‐onset type 2 diabetes and younger current age: increased susceptibility to retinopathy in contrast to other complications

The association of smoking status with glycemic control, metabolic profile and diabetic complications– Results of the Australian National Diabetes Audit (ANDA)

The contribution of diet, physical activity and sedentary behaviour to body mass index in women with and without polycystic ovary syndrome

Contraception use and pregnancy outcomes in women with polycystic ovary syndrome: data from the Australian Longitudinal Study on Women's Health

Impact of different glycaemic treatment targets on pregnancy outcomes in gestational diabetes

The association between Polycystic Ovary Syndrome (PCOS) and metabolic syndrome: a statistical modelling approach

A lifestyle intervention programme for the prevention of Type 2 diabetes mellitus among South Asian women with gestational diabetes mellitus [LIVING study]: protocol for a randomized trial

Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS

Caution in clinical interpretation of population level administrative data

Treatment of Dyslipidemia and Cardiovascular Outcomes: The Journey So Far-Is This the End for Statins?

ADVANCE and glycaemia thresholds: a need to clarify the statistical approach. Reply to Currie CJ [letter]

The contribution of diet, physical activity and sedentary behaviour to body mass index in women with and without polycystic ovary syndrome

Erratum to: Intensive glucose control and risk of cancer in patients with type 2 diabetes

Novel inflammatory markers in overweight women with and without polycystic ovary syndrome and following pharmacological intervention

Semaglutide for the secondary prevention of cardiovascular disease in people with overweight or obesity, but without diabetes: a cost-effectiveness analysis

Early lowering of LDL-C is a more cost-effective strategy than lowering LDL-C later in life: a cost-effectiveness analysis using Mendelian Randomisation

P283 - Déterminants de la variation du poids dans l’étude ADVANCE

Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management

The effects of statins on cardiovascular and inflammatory biomarkers in primary prevention: A systematic review and meta-analysis

Is Semaglutide Cost-Effective for the Secondary Prevention of Cardiovascular Disease in People with Overweight or Obesity in Australia?

Evaluating the Cost-Effectiveness of Immediate Versus 5-Year Risk-Guided Initiation of Treatment for Primary Prevention of Cardiovascular Disease in Australia

Immediate Vs 5-Year Risk-Guided Initiation of Treatment for Primary Prevention of Cardiovascular Disease in 40-Year-Old Australians

EValuation Of PoLygenic Scores and CT ImAging In Risk Factor Modification in Patients with DiabEtes (VOLTAIRE): Rationale and Design

Aktive Filter

Suchergebnisse filtern